Zur Rose Germany

Zur Rose Germany is owned by Zur Rose Group.

Zur Rose Group is a company listed under the stock ticker ROSE (CH).

Zur Rose Group has a direct presence in 2 countries.

Acquisition, funding and merger involving Zur Rose Group.

• Zur Rose Group has just announced a $95 Million fundraising (posted on September 9 2022).

View the org chart displaying its 5 main executives

Most searched biographies at Zur Rose Germany

• Walter Hess, Chief Executive Officer
• Pascal Chatelain, Director, Pharmacy Business
• Benjamin Dust Baumgartner, Human Resources Director

Create your alert
to follow the executive moves at Zur Rose Germany.

Zur Rose Group has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Zur Rose Germany

Social media about Zur Rose Germany

• Zur Rose Germany on Wikipedia, Google News & Yahoo Finance
• Zur Rose Germany on LinkedIn, Twitter & YouTube

Contact by email its executives including Walter Hess

Call Zur Rose Germany at +49 80...

View the org chart

Register to receive your alert

Report an error